Helping End HIV - Gilead Sciences
Gilead Sciences, a leading biopharmaceutical company, reaffirms its commitment to ending the HIV epidemic through continued innovation in treatment and prevention. The company, headquartered in Foster City, California, operates in over 35 countries worldwide, focusing on developing innovative medicines for unmet medical needs.
Gilead's approach involves creating solutions that address the diverse needs of all people affected by HIV. The company's work builds on its legacy in HIV research and treatment, aiming to transform and simplify care for people with life-threatening illnesses globally.
While specific details about new discoveries or products are not provided, Gilead emphasizes its ongoing efforts to contribute to scientific advancements in the field of HIV research and care.
Gilead Sciences, una delle principali aziende biotecnologiche, riconferma il suo impegno a porre fine all'epidemia di HIV attraverso un continuo processo innovativo nel trattamento e nella prevenzione. L'azienda, con sede a Foster City, in California, opera in oltre 35 paesi in tutto il mondo, concentrandosi sullo sviluppo di farmaci innovativi per esigenze mediche insoddisfatte.
L'approccio di Gilead comporta la creazione di soluzioni che rispondano ai diversi bisogni di tutte le persone affette da HIV. Il lavoro dell'azienda si basa sulla sua eredità nella ricerca e nel trattamento dell'HIV, con l'obiettivo di trasformare e semplificare le cure per le persone affette da malattie potenzialmente letali a livello globale.
Sebbene non vengano forniti dettagli specifici su nuove scoperte o prodotti, Gilead sottolinea i suoi sforzi continuativi per contribuire ai progressi scientifici nel campo della ricerca e delle cure per l'HIV.
Gilead Sciences, una empresa biofarmacéutica líder, reafirma su compromiso para acabar con la epidemia del VIH a través de la continua innovación en tratamiento y prevención. La empresa, con sede en Foster City, California, opera en más de 35 países en todo el mundo, centrándose en el desarrollo de medicamentos innovadores para necesidades médicas no cubiertas.
El enfoque de Gilead implica crear soluciones que aborden las diversas necesidades de todas las personas afectadas por el VIH. El trabajo de la empresa se basa en su legado en la investigación y tratamiento del VIH, con el objetivo de transformar y simplificar la atención para las personas con enfermedades potencialmente mortales a nivel global.
Aunque no se proporcionan detalles específicos sobre nuevos descubrimientos o productos, Gilead enfatiza sus esfuerzos continuos por contribuir a los avances científicos en el campo de la investigación y atención del VIH.
길리어드 사이언스는 HIV 전염병 종식을 위한 지속적인 치료 및 예방 혁신을 통해 그들의 헌신을 재확인합니다. 캘리포니아 포스터 시티에 본사를 두고 있는 이 회사는 전 세계 35개국 이상에서 활동하며, 충족되지 않은 의료 요구를 위한 혁신적인 약물을 개발하는 데 주력하고 있습니다.
길리어드의 접근 방식은 HIV에 영향을 받는 모든 사람의 다양한 요구를 해결하는 솔루션을 만드는 것입니다. 이 회사의 작업은 HIV 연구 및 치료에서의 유산을 바탕으로, 생명을 위협하는 질병을 앓고 있는 사람들을 위한 치료를 변화시키고 단순화하는 것을 목표로 합니다.
새로운 발견이나 제품에 대한 구체적인 세부 사항은 제공되지 않지만, 길리어드는 HIV 연구 및 치료 분야에서 과학 발전에 기여하기 위한 지속적인 노력을 강조합니다.
Gilead Sciences, une entreprise biopharmaceutique de premier plan, réaffirme son engagement à mettre fin à l'épidémie de VIH grâce à une innovation continue dans le traitement et la prévention. L'entreprise, dont le siège est situé à Foster City, en Californie, opère dans plus de 35 pays à travers le monde, se concentrant sur le développement de médicaments innovants pour des besoins médicaux non satisfaits.
L'approche de Gilead implique de créer des solutions qui répondent aux divers besoins de toutes les personnes touchées par le VIH. Le travail de l'entreprise repose sur son héritage en recherche et traitement du VIH, visant à transformer et simplifier les soins pour les personnes atteintes de maladies menaçant leur vie à l'échelle mondiale.
Bien que des détails spécifiques sur de nouvelles découvertes ou produits ne soient pas fournis, Gilead souligne ses efforts continus pour contribuer aux avancées scientifiques dans le domaine de la recherche et des soins liés au VIH.
Gilead Sciences, ein führendes biopharmazeutisches Unternehmen, bekräftigt sein Engagement, die HIV-Epidemie durch kontinuierliche Innovation in der Behandlung und Prävention zu beenden. Das Unternehmen mit Hauptsitz in Foster City, Kalifornien, ist in über 35 Ländern weltweit tätig und konzentriert sich auf die Entwicklung innovativer Medikamente für unstillte medizinische Bedürfnisse.
Der Ansatz von Gilead umfasst die Schaffung von Lösungen, die den unterschiedlichen Bedürfnissen aller von HIV betroffenen Personen gerecht werden. Die Arbeit des Unternehmens baut auf seinem Erbe in der HIV-Forschung und -Behandlung auf und zielt darauf ab, die Versorgung für Menschen mit lebensbedrohlichen Krankheiten weltweit zu transformieren und zu vereinfachen.
Obwohl keine spezifischen Details zu neuen Entdeckungen oder Produkten bereitgestellt werden, betont Gilead seine fortlaufenden Bemühungen, zu wissenschaftlichen Fortschritten im Bereich der HIV-Forschung und -Versorgung beizutragen.
- Gilead Sciences is a leader in HIV treatment and prevention
- The company operates in more than 35 countries worldwide
- Gilead focuses on developing innovative medicines for unmet medical needs
- None.
NORTHAMPTON, MA / ACCESSWIRE / September 12, 2024 / Each scientific discovery gets us one step closer to our shared goal of ending the HIV epidemic. As a leader in HIV treatment and prevention, we'll continue to build on our legacy and create innovative solutions to address the diverse needs of all people affected by HIV.
Watch the video to learn more about our work.
Gilead Sciences
Gilead Sciences, Inc. is a research-based biopharmaceutical company that discovers, develops and commercializes innovative medicines in areas of unmet medical need. The company strives to transform and simplify care for people with life-threatening illnesses around the world. Gilead has operations in more than 35 countries worldwide, with headquarters in Foster City, California.
View additional multimedia and more ESG storytelling from Gilead Sciences on 3blmedia.com.
Contact Info:
Spokesperson: Gilead Sciences
Website: https://www.3blmedia.com/profiles/gilead-sciences
Email: info@3blmedia.com
SOURCE: Gilead Sciences
View the original press release on accesswire.com
FAQ
What is Gilead Sciences' (GILD) main focus in HIV research?
How many countries does Gilead Sciences (GILD) operate in?
What is Gilead Sciences' (GILD) approach to ending the HIV epidemic?
What areas does Gilead Sciences (GILD) focus on besides HIV?
